prolaio eVO2peak Module (Version 1.0)
Dec 2025
155d
Prolaio, Inc. has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Adjunctive Cardiovascular Status Indicator . Use the specialty filter in the sidebar to narrow results.